Understanding Dementia Risk: The Role of Sleep and the Glymphatic System

Human sleep consists of two main types: non-REM (slow-wave) sleep and REM (rapid eye movement) sleep. Non-REM sleep has three stages: light sleep, slow-wave sleep, and deep sleep. REM sleep is characterized by vivid dreaming, irregular breathing, and rapid eye movements. The first half of the night is dominated by non-REM sleep, while REM sleep increases in the second half. REM sleep places significant stress on the heart and respiratory system, which is why one of the daily mortality peaks occurs during early morning hours when REM sleep is most prominent.

Sleep is divided into two major phases: REM (Rapid Eye Movement) sleep and non-REM (slow-wave or deep) sleep. During REM sleep, brain activity is nearly indistinguishable from wakefulness. If someone is awakened during this phase, they often report vivid dreams. During non-REM sleep, the brain is less active. This division is fundamental to understanding how the body and mind function during different stages of sleep.

Sleep consists of repeating 90-minute cycles with two main stages: NREM (Non-Rapid Eye Movement) and REM (Rapid Eye Movement). NREM has three stages: Stage 1 is the transition from wakefulness where consciousness remains; Stage 2 involves slower breathing and muscle relaxation; Stage 3 is deep sleep where external stimuli are not responded to, muscles become flaccid, and blood is redirected to muscles for regeneration. REM sleep, also called paradoxical sleep, is the most important phase for brain regeneration and dreaming. When awakened during REM, people feel ripped from deep sleep despite it being lighter. REM lasts approximately 15 minutes and is critical for processing daily problems objectively.

Non-REM Stage 3, also known as deep sleep or slow-wave sleep, is characterized by delta waves—low-frequency, high-amplitude brain waves that look dramatically different from earlier stages. During this stage, it is extremely difficult to wake someone up, as they appear unresponsive to external stimuli. Growth hormone release occurs during this stage, facilitating cellular repair and physical restoration. Additionally, parasomnias such as sleepwalking, sleep talking, and bedwetting typically occur during non-REM Stage 3.

Human sleep consists of two main types—non-rapid eye movement (non-REM) sleep, which includes four stages of increasing depth where the body recharges its immune system, cardiovascular system, and consolidates memories during deep stages three and four; and rapid eye movement (REM) sleep, which brings vivid dreams, emotional processing, and enhanced creativity. These two types alternate in a 90-minute cycle throughout the night, with non-REM dominating the first half and REM increasing in the second half. This structure means that waking up early can disproportionately reduce REM sleep, which is critical for emotional regulation and problem-solving, highlighting why both quantity and quality of sleep matter for overall health.

Alzheimer's disease, the most common dementia subtype (70% of cases), results from accumulation of insoluble proteins in the brain. Two key proteins are involved: beta amyloid forms extracellular plaques, while hyperphosphorylated tau protein accumulates inside neurons forming neurofibrillary tangles. Beta amyloid comes from breakdown of amyloid precursor protein, normally cleaved by alpha, beta, and gamma secretases. When beta secretase acts first followed by gamma secretase, it generates beta amyloid leading to plaque formation. These proteins cause dysfunction and death of neurons. While found in normal brains, Alzheimer's involves significantly higher quantities in specific locations: hippocampus, parietal, and temporal lobes.

Alzheimer's disease involves the pathological accumulation of beta-amyloid and tau proteins in the brain, where beta-amyloid normally supports synaptic function and immune response but becomes toxic when overaccumulated, while tau protein maintains neuronal structure but becomes dysfunctional when overphosphorylated; these proteins accumulate due to impaired glymphatic system clearance, oxidative stress, and reduced acetylcholine secretion, leading to neuroinflammation, neuronal atrophy, and synaptic dysfunction that progressively impair cognitive function.

The most accepted theory of Alzheimer's involves abnormal accumulation of beta-amyloid and tau proteins. Beta-amyloid, normally present in the brain, accumulates over time and becomes toxic, damaging neurons. Tau protein, which normally connects neurons, also becomes abnormal and accumulates excessively, damaging both neurons and their connections (synapses). This pathological process can begin up to 10 years before symptoms appear. Alzheimer's is one specific type of dementia, not the only form. Other causes include vascular dementia, Parkinson's disease dementia, and other neurodegenerative conditions. Having multiple health conditions (uncontrolled hypertension, diabetes, high cholesterol) increases Alzheimer's risk.

Dementia is defined as significant cognitive decline in one or more domains (attention, memory, perceptual-motor skills, language, executive function, social recognition) that interferes with autonomy. The DSM-5 requires evidence of decline documented through neuropsychological testing. Dementia is multifactorial with multiple causes, but shares a common pathological process: protein aggregation. When proteins fail proper lysosomal degradation, they aggregate, generating neuronal stress responses. Different demencias show specific protein inclusions: Alzheimer's (beta-amyloid and tau), Frontotemporal (tau), Lewy body (alpha-synuclein).

Alzheimer's disease involves two key pathological proteins: beta-amyloid, which accumulates as abnormal plaques in the brain, and tau, which forms neurofibrillary tangles; while amyloid accumulation typically precedes tau pathology in Alzheimer's, tau can also cause dementia independently in conditions like frontotemporal dementia and chronic traumatic encephalopathy; importantly, most dementia cases involve mixed pathology combining Alzheimer's with vascular disease, and managing cardiovascular risk factors may influence both amyloid accumulation and cognitive decline.

CSF serves three essential functions: providing buoyancy to reduce brain weight, offering mechanical protection by cushioning against impacts, and maintaining chemical stability by removing waste and regulating the neural environment. CSF circulates through a defined pathway: produced in choroid plexuses, moved by ciliary action through lateral → third → fourth ventricles, then exiting through median and lateral apertures into subarachnoid spaces surrounding the brain and spinal cord.

Cerebrospinal fluid (CSF) is a filtrate of plasma produced by the choroid plexus within brain ventricles. It differs from plasma in having lower protein content but contains glucose, oxygen, vitamins, and ions. CSF serves multiple critical functions: it acts as a cushion protecting the brain and spinal cord from mechanical trauma, provides nutrients to neural tissue, and removes metabolic waste products. CSF circulates through the ventricular system, then flows into the subarachnoid space surrounding the brain and spinal cord. A blood-CSF barrier exists between the capillaries of the choroid plexus and the CSF, maintaining chemical stability. The choroid plexus consists of fenestrated capillaries covered by ependymal cells that secrete CSF into the ventricular system.

Cerebrospinal fluid (CSF) is a clear liquid that bathes the central nervous system (brain and spinal cord), serving multiple critical functions including mechanical protection against shocks and vibrations, regulation of intracranial pressure, and facilitation of cerebral metabolic processes through substance exchange. CSF is produced by the choroid plexus located in the ventricular system, which consists of four interconnected ventricles (two lateral ventricles, third ventricle, and fourth ventricle) connected by channels such as the foramina of Monro and aqueduct of Sylvius. CSF circulates through two main compartments: the inner ependymal cavities (ventricles) and the sub-arachnoid space surrounding the CNS. After leaving the fourth ventricle through the foramen of Magendie to fill the sub-arachnoid space, CSF is ultimately absorbed at the top of the skull through arachnoid granulations of Pacchioni.

CSF circulation follows a predominantly caudal direction, though some authors describe a more complex bidirectional flow pattern. In the posterior region, particularly through the central canal of the spinal cord, CSF flows in a descending manner, while in the anterior region, CSF flows in an ascending direction. This creates a turbulent, oscillating movement that allows CSF to effectively bathe and protect neural structures. Several mechanisms drive CSF circulation: pulsations from cerebral arteries create rhythmic movement, the weight of brain structures combined with body movements generates additional flow, and pressure differences between the ventricular system, subarachnoid space, and venous system facilitate movement. Increased intracranial pressure can impede CSF circulation, while respiratory movements also contribute to dynamic flow.

The ventricular system consists of four interconnected brain cavities—the two lateral ventricles (C-shaped in each cerebral hemisphere), third ventricle (midline diencephalon), and fourth ventricle (between brainstem and cerebellum)—that produce, circulate, and reabsorb cerebrospinal fluid (CSF). CSF flows from lateral ventricles through interventricular foramina (of Monroe) to the third ventricle, then through the cerebral aqueduct (Sylvian aqueduct) to the fourth ventricle, exiting via lateral apertures (of Luschka) and median aperture (of Magendie) into the subarachnoid space, where it is reabsorbed through arachnoid granulations into dural venous sinuses. The choroid plexus lining the ventricles produces most CSF, which provides buoyancy, protection, chemical stability, and waste removal for the central nervous system.